journal article·2010-02-23

[Gd@C82(OH)22]n Nanoparticles Induce Dendritic Cell Maturation and Activate Th1 Immune Responses

De Yang, Yuliang Zhao, Hua Guo, Yana Li, Poonam Tewary, Gengmei Xing, Wei Hou, Joost J. Oppenheim, Ning Zhang

ACS Nano· Volume 4· Issue 2
Publisher page

Abstract

Dendritic cells play a pivotal role in host immune defense, such as elimination of foreign pathogen and inhibition of tumorigenesis. In this paper, we report that [Gd@C(82)(OH)(22)](n) could induce phenotypic maturation of dendritic cells by stimulating DC production of cytokines including IL-12p70, upregulating DC co-stimulatory (CD80, CD83, and CD86) and MHC (HLA-A,B,C and HLA-DR) molecules, and switching DCs from a CCL5-responsive to a CCL19-responsive phenotype. We found that [Gd@C(82)(OH)(22)](n) can induce dendritic cells to become functionally mature as illustrated by their capacity to activate allogeneic T cells. Mice immunized with ovalbumin in the presence of [Gd@C(82)(OH)(22)](n) exhibit enhanced ovalbumin-specific Th1-polarized immune response as evidenced by the predominantly increased production of IFNgamma, IL-1beta, and IL-2. The [Gd@C(82)(OH)(22)](n) nanoparticle is a potent activator of dendritic cells and Th1 immune responses. These new findings also provide a rational understanding of the potent anticancer activities of [Gd@C(82)(OH)(22)](n) nanoparticles reported previously.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Nanoplatforms for cancer theranostics · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Tianjin Medical University, Research Center of Basic Medic Sciences, Cancer Institute and Hospital, Key Laboratory of Breast Cancer Research (Ministry of Education), Tianjin 300060, China

Basic Research Program, SAIC-Frederick, Inc., Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland 21702

Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China, and National Center for Nanoscience and Technology of China

References (34)

Show source-provided references
1. Chaput N. · Oncogene · 2008 · 27 · 592010.1038/onc.2008.270 ↗
2. Bosi S. · Eur. J. Med. Chem. · 2003 · 38 · 91310.1016/j.ejmech.2003.09.005 ↗
3. Tang J. · J. Nanosci. Nanotechnol. · 2007 · 7 · 108510.1166/jnn.2007.301 ↗
4. Schinazi R. F. · Antimicrob. Agents Chemother. · 1993 · 37 · 170710.1128/AAC.37.8.1707 ↗
5. Friedman S. H. · J. Med. Chem. · 1998 · 41 · 242410.1021/jm970689r ↗
6. Mashino T. · Bioorg. Med. Chem. Lett. · 2005 · 15 · 110710.1016/j.bmcl.2004.12.030 ↗
7. Dugan L. L. · Neurobiol. Dis. · 1996 · 3 · 12910.1006/nbdi.1996.0013 ↗
8. Dugan L. L. · Parkinsons Relat. Disord. · 2001 · 7 · 24310.1016/S1353-8020(00)00064-X ↗
9. Laakkonen P. · Proc. Natl. Acad. Sci. U.S.A. · 2004 · 101 · 938110.1073/pnas.0403317101 ↗
10. Fumelli C. · J. Invest. Dermatol. · 2000 · 115 · 83510.1046/j.1523-1747.2000.00140.x ↗
11. Pantarotto D. · Mini-Rev. Med. Chem. · 2004 · 4 · 805
12. Chen Y. B. · J. Surg. Oncol. · 2009 · 100 · 38210.1002/jso.21329 ↗
13. Mashino T. · Bioorg. Med. Chem. Lett. · 1999 · 9 · 295910.1016/S0960-894X(99)00515-6 ↗
14. Tsao N. · Antimicrob. Agents Chemother. · 2001 · 45 · 178810.1128/AAC.45.6.1788-1793.2001 ↗
15. Tegos G. P. · Chem. Biol. · 2005 · 12 · 112710.1016/j.chembiol.2005.08.014 ↗
16. Bianco A. · J. Pept. Sci. · 2001 · 7 · 20810.1002/psc.313 ↗
17. Wharton T. · Bioorg. Med. Chem. · 2002 · 10 · 354510.1016/S0968-0896(02)00252-3 ↗
18. Cagle D. W. · Proc. Natl. Acad. Sci. U.S.A. · 1999 · 96 · 518210.1073/pnas.96.9.5182 ↗
19. Mikawa M. · Bioconjugate Chem. · 2001 · 12 · 51010.1021/bc000136m ↗
20. Bolskar R. D. · J. Am. Chem. Soc. · 2003 · 125 · 547110.1021/ja0340984 ↗
21. Chen C. · Nano Lett. · 2005 · 5 · 205010.1021/nl051624b ↗
22. Banchereau J. · Annu. Rev. Immunol. · 2000 · 18 · 76710.1146/annurev.immunol.18.1.767 ↗
23. Sozzani S. · J. Immunol. · 1997 · 159 · 199310.4049/jimmunol.159.4.1993 ↗
24. Sugai T. · Vaccine · 2005 · 23 · 545010.1016/j.vaccine.2004.09.041 ↗
25. Mesa C. · Vaccine · 2004 · 22 · 304510.1016/j.vaccine.2004.02.010 ↗
26. Elamanchili P. · Vaccine · 2004 · 22 · 240610.1016/j.vaccine.2003.12.032 ↗
27. Uto T. · J. Immunol. · 2007 · 178 · 297910.4049/jimmunol.178.5.2979 ↗
28. Mottram P. L. · Mol. Pharmaceutics · 2007 · 4 · 7310.1021/mp060096p ↗
29. Fifis T. · J. Immunol. · 2004 · 173 · 314810.4049/jimmunol.173.5.3148 ↗
30. Wang J. · Biochem. Pharmacol. · 2006 · 71 · 87210.1016/j.bcp.2005.12.001 ↗
31. Akasaka T. · J. Am. Chem. Soc. · 2008 · 130 · 1284010.1021/ja802156n ↗
32. Wang L. · Nano Lett. · 2005 · 5 · 234010.1021/nl050730a ↗
33. Liu Y. · Biomaterials · 2009 · 30 · 393410.1016/j.biomaterials.2009.04.001 ↗
34. Kurosaka K. · J. Immunol. · 2005 · 174 · 625710.4049/jimmunol.174.10.6257 ↗